معرفی
Dr. Matt Johansen is a Chancellor's Research Fellow at the Centre for Inflammation, University of Technology Sydney (UTS). His work focuses on mycobacterial pathogenesis, SARS-CoV-2 infection, and vaccine development. He holds a Bachelor of Animal and Veterinary Bioscience with Honours (University of Sydney, 2013) and a PhD in Veterinary Microbiology & Immunology (University of Sydney, 2017). Dr. Johansen's research integrates animal models (e.g., zebrafish, mice) and advanced in vitro systems to study host-pathogen interactions, particularly targeting non-tuberculous mycobacteria (NTM) and coronaviruses.
Research Interests: Mycobacterial pathogenesis, SARS-CoV-2 infection mechanisms, vaccine development, host immune responses, and translational drug discovery.
Recent Trends in Articles: Dr. Johansen's publications emphasize vaccine design against emerging sarbecoviruses, mechanisms of NTM virulence, and the impact of smoking on cytokine regulation. His work bridges basic science and clinical applications, with a focus on therapies for respiratory diseases such as preeclampsia, COPD, and ARDS.
Grants & Collaborations: He leads projects funded by NSW Health, NHMRC, and UTS, focusing on mRNA vaccines, anti-inflammatory compounds, and lipid nanoparticle delivery systems. Collaborations include the Centenary Institute, Hudson Institute, and international teams in France and the U.S.
Labs & Teams: Active in the Centre for Inflammation, contributing to infectious disease programs targeting high-risk pathogens like Mycobacterium tuberculosis and SARS-CoV-2. Engages in interdisciplinary teams for drug discovery and zebrafish modeling.
